insights_auto
Nega ALNOV tushdi 3,64%?
Batafsil oʻrganishchevron_right
ALNOV:EPA
Novacyt SA
0,41 €
arrow_downward
-3,64%(-0,016) 1K
5-noy, 17:35:20 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALNOV tikeri uchun statistika yaratilmoqda...
Ochish
0,42 €
Yuqori
0,43 €
Past
0,41 €
Bozor kapitali
31,91 mln
Oʻrtacha hajm
198,56 ming
Hajmi
133,90 ming
52 haftalik eng yuqori
1,04 €
52 haftalik eng past
0,29 €
Aksiya boʻyicha daromad
-0,38 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
228
Ochish
0,42 €
Yuqori
0,43 €
Past
0,41 €
Bozor kapitali
31,91 mln
Oʻrtacha hajm
198,56 ming
Hajmi
133,90 ming
52 haftalik eng yuqori
1,04 €
52 haftalik eng past
0,29 €
Aksiya boʻyicha daromad
-0,38 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
228
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Fox Business
·
37 daqiqa oldin
Stocks plunge as Dem midterm sweep fuels AI regulatory concerns
Quantisnow
·
3 daqiqa oldin
TransUnion Appoints David Gilbert as Interim Chief Financial Officer
FinancialContent
·
22 daqiqa oldin
FinancialContent - Kratos (NASDAQ:KTOS) posts Q3 2026 sales in line with estimates, quarterly revenue guidance slightly exceeds expectations
The Motley Fool
·
23 daqiqa oldin
1 Turnaround Stock I Own Just Jumped 14% Even As the Nasdaq Plunged. Here’s Why I’d Still Buy More.
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA haqida
CEODavid Allmond
Xodimlar soni228
Asos solingan3-iyl, 2006
Bosh ofislar-
SektorHealth Care
Industry-
Veb-saytnovacyt.com